Pinnacle Ventures

Pinnacle operates distinct equity and venture debt vehicles that can invest separately or alongside one another. The equity funds target minority stakes in growth-stage technology and healthcare companies, while the debt funds provide term loans and working capital facilities to venture-backed businesses, typically post-product-market fit. This structure allows Pinnacle to maintain upside through equity while generating current income from its loan portfolio, a combination that few venture firms pursue at scale.

Kenneth B. Sawyer and Robert M. Sawyer serve as Managing Directors and co-head the firm's investment activities. Both are involved in equity and debt allocation decisions, with Robert's prior experience at Western Technology Investment informing the firm's venture debt underwriting approach. The firm maintains a relatively flat decision-making structure consistent with its boutique operating model.

Pinnacle primarily makes direct investments — both equity and debt — into individual companies rather than committing as a limited partner to third-party venture funds. Its model is built on direct origination and bilateral negotiation with portfolio companies, giving it control over deal terms and capital structure design that a fund-of-funds approach would not provide.

The firm concentrates on late-stage and growth equity rounds for its equity vehicles, typically after a company has demonstrated product-market fit and meaningful revenue traction. Its venture debt practice can engage earlier, providing working capital solutions to companies that have raised institutional equity from venture firms but need additional runway between rounds. Seed and early-stage equity is not a material part of the current strategy.

Pinnacle does not publicly publish a formal exclusion list, but observable deal flow suggests limited activity in capital-intensive industries such as cleantech hardware, semiconductor fabrication, and traditional energy. The firm's historical portfolio is concentrated in asset-light technology and healthcare services companies where intellectual property and recurring revenue models support both equity appreciation and debt service capacity.